Vivani Medical, Inc. Income Statement
VANI|3 years of annual SEC 10-K data (FY2015-FY2017)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
Vivani Medical, Inc. reported $9M in revenue and $20M in net loss for FY2017. Revenue has grown at a 139.1% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Revenue | $8.9M | $3.4M | $1.6M |
| Cost of Revenue | $5.3M | $3.6M | $5.6M |
| Gross Profit | $3.7M | -$160.0K | -$4.1M |
| SG&A Expense | $8.2M | $6.6M | $4.2M |
| R&D Expense | $3.0M | $5.0M | $3.2M |
| Operating Income | -$20.0M | -$21.2M | -$18.0M |
| Interest Expense | - | - | $8.0K |
| Net Income | -$20.0M | -$35.2M | -$23.0M |
| EPS (Diluted) | -$0.56 | -$1.41 | -$1.02 |
| Shares Outstanding | 42.7M | 25.1K | 35.2K |
| Gross Margin | 40.9% | -4.7% | -259.7% |
| Operating Margin | -224.0% | -624.5% | -1150.0% |
| Profit Margin | -223.7% | -1035.3% | -1467.7% |